The Consensus Molecular Subtypes is a predictive biomarker for anti-EGFR antibody effect in metastatic colorectal cancer

被引：0
|
作者：
Okita, Akira [1 ]
Takahashi, Shin [1 ]
Ouchi, Kota [1 ]
Yamada, Yasuhide
Takahashi, Masanobu [1 ]
Ishioka, Chikashi [1 ]
机构：
[1] Tohoku Univ, Dept Cli Onco, IDAC, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Colorectal cancer; CMS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2212
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [1] Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer
    Augustine, T. A.
    Baig, M.
    Sood, A.
    Budagov, T.
    Atzmon, G.
    Mariadason, J. M.
    Aparo, S.
    Maitra, R.
    Goel, S.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 313 - 318
  • [2] Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer
    T A Augustine
    M Baig
    A Sood
    T Budagov
    G Atzmon
    J M Mariadason
    S Aparo
    R Maitra
    S Goel
    British Journal of Cancer, 2015, 112 : 313 - 318
  • [3] Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer
    Cripps, C.
    Gill, S.
    Ahmed, S.
    Colwell, B.
    Dowden, S.
    Kennecke, H.
    Maroun, J.
    Samson, B.
    Thirlwell, M.
    Wong, R.
    CURRENT ONCOLOGY, 2010, 17 (06) : 272 - 278
  • [4] Clinical translation of predictive markers for anti-EGFR monoclonal antibody therapy in metastatic colorectal cancer
    Rowland, Andrew
    Karapetis, Christos S.
    Mangoni, Arduino A.
    Wiese, Michael D.
    Kichenadasse, Ganessan
    McKinnon, Ross A.
    Sorich, Michael J.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S31 - S34
  • [5] EGFR protein expression of the metastatic colorectal cancer as a prognostic/predictive factor for anti-EGFR antibody therapy.
    Timar, Jozsef
    Piurko, Violetta
    Kenessey, Istvan
    Raso, Erzsebet
    Lahm, Erika
    Kiss, Edina
    Sikter, MArta
    Vachaja, Jozsef
    Papai, Zsuzsa
    Uhlyarik, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
    Lo Nigro, Cristiana
    Ricci, Vincenzo
    Vivenza, Daniela
    Granetto, Cristina
    Fabozzi, Teresa
    Miraglio, Emanuela
    Merlano, Marco C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (30) : 6944 - 6954
  • [7] Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
    Cristiana Lo Nigro
    Vincenzo Ricci
    Daniela Vivenza
    Cristina Granetto
    Teresa Fabozzi
    Emanuela Miraglio
    Marco C Merlano
    World Journal of Gastroenterology, 2016, (30) : 6944 - 6954
  • [8] ANTI-EGFR ANTIBODY RECHALLENGE IN CHEMOREFRACTORY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Kumagai, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Esaki, Taito
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] Consensus molecular subtypes (CMS) of colorectal cancer predict anti-EGFR response irrespective of tumor sidedness
    Chowdhury, Saikat
    Gupta, Ria
    Haridas, Valsala
    Zeineddine, Mohammad A.
    Kopetz, Scott
    Shen, John Paul
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
    Ciardiello, Davide
    Martini, Giulia
    Famiglietti, Vincenzo
    Napolitano, Stefania
    De Falco, Vincenzo
    Troiani, Teresa
    Latiano, Tiziana Pia
    Ros, Javier
    Elez Fernandez, Elena
    Vitiello, Pietro Paolo
    Maiello, Evaristo
    Ciardiello, Fortunato
    Martinelli, Erika
    CANCERS, 2021, 13 (08)
12345